S2-013 and CFPAC-1 cells were treated with brequinar for 16hr or 2 weeks at two different doses and bulk RNAseq was performed.
| Accession | PRJNA1099696 |
| Data Type | Raw sequence reads |
| Scope | Multispecies |
| Grants | - "Targeting MUC1-induced Tumor-stromal Metabolic Cross-talk in Pancreatic Cancer: Targeting MUC1-Mediated Tumor-Stromal Metabolic Cross-Talk in Pancreatic Cancer" (Grant ID R01 CA163649, National Cancer Institute)
- "Molecular Basis of ME2-mediated Tumor Suppression in Pancreatic Cancer" (Grant ID R01 CA270234, National Cancer Institute)
- "Pancreatic Cancer ARTNet Center" (Grant ID U54 CA274329, National Cancer Institute)
|
| Submission | Registration date: 12-Apr-2024
OUHSC |
| Relevance | Medical |
Project Data:
| Resource Name | Number
of Links |
|---|
| Sequence data |
| SRA Experiments | 10 |
| Other datasets |
| BioSample | 10 |